Evotec Divests API Manufacturing Facility to Monacum Partners

Evotec SE, a life sciences company, has sold its chemical API manufacturing site, Evotec DS GmbH, located in Halle/Westphalia, to Monacum Partners. This Munich-based private equity firm will take over operations to expand the business under the new name DAPIN GmbH. The transaction aligns with Evotec's strategic "Priority Reset" initiative aimed at focusing on core competencies for profitable growth. The divestment permits Evotec to concentrate resources on key growth drivers.

The transition guarantees that all current employees at Evotec DS will continue their roles. Both companies see growth potential in this transfer, although financial terms were not disclosed. Monacum Partners aims to leverage its expertise in repositioning businesses to elevate the operational performance of the acquired facility.